avg. Impact Factor

Most Cited Articles of State Key Laboratory of Oncology in South China

Glycolysis inhibition for anticancer treatmentOncogene20061.1K
Nasopharyngeal carcinomaLancet, The2019747
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N-Methyladenosine RNA DemethylaseCancer Cell2017736
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trialLancet Oncology, The2016691
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?Cancer Communications2019674
IBS: an illustrator for the presentation and visualization of biological sequencesBioinformatics2015473
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysisLancet Oncology, The2015453
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trialLancet Oncology, The2015428
Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III studyJournal of Clinical Oncology2014407
Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR MutationJournal of Thoracic Oncology2015390
Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolismNature2016388
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinomaNature Materials2017387
Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancerCancer Cell2014314
Association of the Asp312Asn and Lys751Gln polymorphisms in the XPD gene with the risk of non-Hodgkin's lymphoma: evidence from a meta-analysisChinese Journal of Cancer2015298
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal CarcinomaNew England Journal of Medicine2019297
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trialAnnals of Oncology2017296
METTL3 facilitates tumor progression via an mA-IGF2BP2-dependent mechanism in colorectal carcinomaMolecular Cancer2019288
mA Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in CancerCancer Cell2020275
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trialLancet, The2016269
Targeting calcium signaling in cancer therapyActa Pharmaceutica Sinica B2017267
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical TrialJournal of Clinical Oncology2018267
A Deep Learning-Based Radiomics Model for Prediction of Survival in Glioblastoma MultiformeScientific Reports2017258
EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapyOncotarget2014246
Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinomaOncotarget2014237
Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization StudyJAMA Oncology2017236